A monoclonal antibody, BBG-25, raised in BALB/c mice demonstrated specificity for Bacteroides gingivalis lipopolysaccharide. Immunoblotting indicated that this monoclonal antibody does not cross-react with lipopolysaccharide prepared from enterobacterial organisms or from other Bacteroides species.
Anaerobes comprise a significant proportion of the oral and dental microflora, and a number of these anaerobic bacteria have been implicated as pathogenic (14) . The anaerobic, black-pigmented, gram-negative oral bacterium Bacteroides gingivalis, in particular, has been associated with clinical signs of adult chronic periodontitis (17, 19, 21-23, 25, 26) .
For a pathogen to be successful in causing disease, it must enter the host, multiply in host tissue, avoid or not stimulate host defenses, and damage the host (20) . Several bacterial surface components and end products of growth and metabolism have been implicated as virulence factors which may be involved in host tissue destruction in periodontal disease (5, 18) . One such component that has received much attention as a potential virulence factor is lipopolysaccharide (LPS).
LPS is a major component of the outer membrane of gram-negative bacteria. It is essential for maintaining the integrity and functional conformation of the membrane and, consequently, of the intact cell. A wide range of physiopathological reactions expressed during many gram-negative bacterial infections have been attributed to this compound and, in particular, to the lipid A component (2, 3, 11, 15) .
Bacteroides LPS are atypical. The biological potency of B. gingivalis LPS is low compared with that of LPS from gram-negative enteric organisms (8, 12) , except for its potency in stimulating bone resorption of fetal rat bones in organ culture (4, 6) and its inhibition of bone collagen synthesis in fetal rat calvaria (10) . Furthermore, LPS from all Bacteroides species analyzed to date lack 2-keto-3-deoxyoctulosonic acid, L-glycero-D-mannoheptulose, and 3-hydroxytetradecanoic acid (8, 12) , components of the core and lipid A regions of LPS (11, 16) Tables 1 and 2) , was then applied to each well and allowed to gravity flow for 1 h. The samples were washed under vacuum as previously described. Goat anti-mouse immunoglobulin G conjugated to horseradish peroxidase (100 Ftl/well; 1:3,000 dilution: Bio-Rad) was added and allowed to gravity flow for 30 min to 1 h, followed by three washes of washing buffer under vacuum. The nitrocellulose membrane was removed and placed in the color development solution (1 part of 4-chloro-1-naphthol in methanol [3 mg/ml] and 5 parts of 0.018% hydrogen peroxide in 20 mM Tris hydrochloride-500 mM NaCI [pH 7.5]) for 3 to 5 min. The nitrocellulose membrane was rinsed three times in washing buffer, rinsed thoroughly in distilled water, and dried for storage.
When tested by immunoblot against purified LPS preparations from members of the family Enterobacteriaceae, MAb BBG-25 did not respond (Table 1) . In this case, two purified LPS preparations from B. gingivalis 381 served as positive controls. We have previously shown (10) that these components represent high-and low-molecular-weight LPS species, Peak 2 and Peak 3, respectively, which differ in the size of the carbohydrate side chains associated with the lipid moiety. The possibility that the determinant is present on these enteric LPS molecules but is masked in some way, e.g., by steric hindrance by the polysaccharide chain, was considered. However, the finding that none of the R mutants of S. minnesota were reactive tends to exclude this possibility. Another possible explanation for the lack of response of enteric LPS to the MAb could be the inability of the LPS to bind to the nitrocellulose. However, by silver staining (9) we were able to demonstrate that the LPS, at levels as low as 1 p.g, was present on the nitrocellulose. These results suggest that the determinant for the MAb BBG-25 is not present in these enteric LPS molecules. A similar lack of cross-reactivity between MAbs to B. fragilis LPS and LPS extracted from enterobacterial organisms has previously been demonstrated by an enzyme inhibition immunoassay (7) .
The LPS-containing fractions from the different Bacteroides species showed that MAb BBG-25 responded positively to LPS from all the B. gingivalis strains tested but demonstrated no cross-reactivity to LPS of any of the other Bacteroides species tested (Table 2) . Recently, a similar result with a MAb to B. gingivalis LPS has been demonstrated in an enzyme-linked immunosorbent assay (13) . This result indicates that there is a common antigenic determinant present in B. gingivalis LPS molecules that is unique to B.
gingivalis.
The weak response of the MAb to cells of B. gingivalis 381, the parent organism, and to cells of the other B. gingivalis strains ( Table 2 ) would suggest that the epitope for the MAb BBG-25 in intact bacteria is not readily accessible at the cell surface. Interestingly, the MAb BBG-25 demonstrates an intense response to the low-molecular-weight LPS species, Peak 3, which has shorter O-antigenic carbohydrate side chains associated with the lipid moiety (10) . As the lipid component is in the outer membrane, this response suggests that the domain containing the epitope for the MAb is also closely associated with the outer membrane rather than being present as a surface antigen. This finding would be consistent with the weak response to intact bacteria.
In any study correlating a biological activity with a specific 
